


Healthcare News Roundup: LIcensing
HSMN NewsFeed - 12 Oct 2006
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA
HSMN NewsFeed - 5 Oct 2006
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
HSMN NewsFeed - 29 Sep 2006
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
HSMN NewsFeed - 26 Sep 2006
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
HSMN NewsFeed - 19 Sep 2006
Amgen Announces License Agreement with Yeda Research and Development Company Ltd.
Amgen Announces License Agreement with Yeda Research and Development Company Ltd.
HSMN NewsFeed - 19 Sep 2006
ImClone Systems Issues Statement on Court Ruling in Litigation against Yeda
ImClone Systems Issues Statement on Court Ruling in Litigation against Yeda
HSMN NewsFeed - 18 Sep 2006
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
HSMN NewsFeed - 18 Sep 2006
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
HSMN NewsFeed - 18 Sep 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
HSMN NewsFeed - 18 Sep 2006
Somanetics Signs Contract Development and Exclusive Licensing Agreement for Several Novel Technologies
Somanetics Signs Contract Development and Exclusive Licensing Agreement for Several Novel Technologies
HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
HSMN NewsFeed - 7 Sep 2006
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
